Genesis 2025 (from lab to the market)

Genesis 2025 (from lab to the market)

We bring to your attention this course organized by an association of students specialized in biotechnology and bioengineering, which aims to provide the knowledge, skills and network needed to transform scientific discoveries into concrete solutions for patients, through the creation of entrepreneurial initiatives or commercial licenses.
Students of the Master of Science in Biotechnology who are admitted to the course will be recognized 2 CFU as Elective courses following the certification of actual participation in the course and the presentation of a final report.
Apply Now & become part of our community!
Academic Agenda

CALL FOR ERASMUS+ MOBILITY FOR STUDY A.Y. 2025/26

CALL FOR ERASMUS+ MOBILITY FOR STUDY A.Y. 2025/26

The call for application for the 2025/26 Erasmus+ programme is available for students of Tor Vergata University
ERASMUS+ Programme, Key Action 1 Student Mobility for study and traineeship, based on bilateral/multilateral agreements between European Universities and Tor Vergata University of Rome is now available.
Application & Deadline
The application will be submitted exclusively online, by filling in the application form available at the link:
https://mobint.uniroma2.it/erasmus/candidatura/Default.aspx

The deadline for submitting the form is on March 3rd, 2025, at 12 pm.

Contacts Erasmus+ Central Office

Tel. +39 06 7259 2555/2062
E-mail: outgoing@erasmus.uniroma2.it

INTERNATIONAL OPEN DAY

INTERNATIONAL OPEN DAY

Schools of Economics, Engineering, Humanities, Law, Mathematics, Physics and Natural Sciences and Medicine and Surgery, Tor Vergata University of Rome.

On January 22, 2025, from 03:00 to 04.00 p.m. (CEST Time) Tor Vergata University of Rome is pleased to invite you to the International Open Day, the event dedicated to the presentation of the English-taught degree courses offered by the Schools of Economics, Engineering, Humanities, Law, Mathematics, Physics and Natural Sciences and Medicine and Surgery.

On this occasion, you will also learn about the specific requirements for admission to the above courses, tuition fees and scholarships, accommodation, and how to enjoy your life in Rome. You can take a Virtual Tour of our University and learn about all the opportunities our community offers to each student. This will help you decide on your future at Tor Vergata University of Rome.

Click here to register for the International Open Day. You will then receive an email with a link to access the event platform www.utov.it/iod .

In the meantime meet our Student Ambassadors: SAP PROGRAM

Fondazione Rome Technopole -AWARD 2024 – Call for the awarding of scholarships open to L-2 graduates enrolled in the LM in Biotechnology

Fondazione Rome Technopole -AWARD 2024 – Call for the awarding of scholarships open to L-2 graduates enrolled in the LM in Biotechnology

As part of the policies to attract young graduates to the Universities of the Lazio Region, strengthened by the Fondazione Rome Technopole, a public call for applications has been issued for the awarding of 480 scholarships of 1,000 euros each with the aim of enhancing the second level university courses of the Lazio Region whose educational offering is consistent with the strategic areas of the Rome Technopole.

More information at the website

The recipients include students with a three-year degree in class L-2 (Biotechnology) who enroll in the master’s degree in Biotechnology

APPLICATION SUBMISSION
The applications for participation can be submitted starting from 2:00 pm on 14/10/2024, through the platform available at the address

Why enroll with us?!

housing

1) sector studies (see Assobiotec reports at https://assobiotec.federchimica.it/) show that the Biotechnology sector is also rapidly expanding in Italy
2) Employment data reported by Almalaurea indicate that three years after graduation, 92.7% of graduates in Industrial Biotechnology (LM-8) in Italy are engaged in paid work. This figure is higher than the average for graduates in Medical Biotechnology LM-9 (88.1%), Agricultural Biotechnology LM-7 (87%) or in master’s degrees in the biological area LM-6 (84.9%);
3) Three years after graduation, between 2019 and 2023, employment data for graduates of the MSc in Biotechnology from the University of Rome Tor Vergata have always been higher than the national average (Almalaurea).
4) In 2023, 100% of graduates declared that they were overall satisfied with the course (ANVUR data)
5) The MSc in Biotechnology at the University of Rome Tor Vergata is the LM-8 course in Italy with the highest internationalization index (ANVUR data)
6) Our courses involve professionals from biotechnology companies and the world of Clinical Research to promote a connection between university teaching and the world of work
7) The Master’s Degree in Biotechnology offers a Curriculum in Clinical Research, unique in Italy. It is the first and so far the only Master’s program in Italy aimed at training students with all the necessary knowledge to perform essential and leading roles in the world of clinical research (Data Manager, Clinical Research Associate, Clinical Research Coordinator). All graduates from this curriculum have all found a very rapid job placement. Follow the link here for more information

Experimental Thesis in Neurobiology at the Laboratory of Prof. Antonella Ragnini

Admission Procedure at the Master of Science in Biotechnology of Tor Vergata University of Rome

We are seeking highly motivated students to undertake a laboratory experimental study for Master Thesis (LM) in Biotechnology.
Possibility to start in September -December 2024.
Project Title: Study of the mechanism of action drugs promoting remyelination in cellular models.
Remyelination is the natural process that restores the myelin of damaged axons in the adult brain. Myelin can be disrupted during life as a consequence of injury, viral infection or disease progression. Remyelination can restore saltatory current and thereby neuronal function. Unfortunately, remyelination is incomplete as a consequence of disease progression or ageing. Cumulating data suggest that pharmacological intervention can be used to restore the ability of neural stem cells to mature into myelinating Ols. We previously selected some promising drugs that need to be studied to clarify their molecular mechanism of action (Al Jaf et al., Cells 2024). Understanding how remyelination occurs in adult CNS in normal and pathological conditions will open new avenues for the possibility of treating neurodegenerative diseases among which are Multiple Sclerosis, Alzheimer’s, Parkinson and ageing-related dementia. Drug screening, HTS imaging and analyses, qPCR and CRISP-CAS9 KO and Knock-in are among the methodologies that you will learn during the thesis.
For position enquire please e-mail to: antonella.ragnini@uniroma2.it